The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...
The government agency says X no longer suits its communication needs.
The use of the ESMP will become mandatory for MAHs and NCAs as of Sunday, February 2. The platform is a key requirement of ...
The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike. Following a turbulent period marked by Brexit and the ...
The first version of the European Shortages Monitoring Platform (ESMP) has gone live to help marketing authorisation holders (MAHs) report shortages of centrally authorised medicines. Yesterday ...